C. Vayssière, L. Sentilhes, A. Ego, C. Bernard, D. Cambourieu et al., Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.193
DOI : 10.1016/j.ejogrb.2015.06.021

C. Geyl, E. Clouqueur, J. Lambert, D. Subtil, V. Debarge et al., Liens entre pr????clampsie et retard de croissance intra-ut??rin, Gyn??cologie Obst??trique & Fertilit??, vol.42, issue.4, pp.229-262, 2014.
DOI : 10.1016/j.gyobfe.2014.01.008

E. Grandone, M. Villani, and G. Tiscia, Aspirin and heparin in pregnancy, Expert Opinion on Pharmacotherapy, vol.8, issue.8, pp.1793-803, 2015.
DOI : 10.1016/j.fertnstert.2011.10.038

E. Bujold, S. Roberge, and K. Nicolaides, Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation, Prenatal Diagnosis, vol.307, issue.21, pp.642-650, 2014.
DOI : 10.1001/jama.2012.5034

E. Kozer, S. Nikfar, A. Costei, R. Boskovic, I. Nulman et al., Aspirin consumption during the first trimester of pregnancy and congenital anomalies: A meta-analysis, American Journal of Obstetrics and Gynecology, vol.187, issue.6
DOI : 10.1067/mob.2002.127376

J. Nizard, Pr??vention du RCIU vasculaire, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.42, issue.8, pp.1008-1025, 2013.
DOI : 10.1016/j.jgyn.2013.09.022

L. Askie, L. Duley, D. Henderson-smart, and L. Stewart, Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. The Lancet, p.26

. Société-française-d-'anesthésie-et-de-réanimation, Collège national des gynécologues et obstétriciens français (CNGOF), Société française de médecine périnatale (SFMP), Société française de néonatalogie (SFNN). [Multidisciplinary management of severe pre-eclampsia (PE). Experts' guidelines 2008. Société française d'anesthésie et de réanimation Collège national des gynécologues et obstétriciens français

H. Madar, S. Brun, F. Coatleven, A. Nithart, C. Lecoq et al., Pour une prescription ciblée de l'aspirine. Gynécologie Obstétrique Fertilité & Sénologie, pp.224-254, 2017.
DOI : 10.1016/j.gofs.2017.02.001

S. Roberge, K. Nicolaides, S. Demers, J. Hyett, N. Chaillet et al., The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis, American Journal of Obstetrics and Gynecology, vol.216, issue.2, pp.110-120, 2017.
DOI : 10.1016/j.ajog.2016.09.076

E. Bujold, S. Roberge, Y. Lacasse, M. Bureau, F. Audibert et al., Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy, Obstetrics & Gynecology, vol.116, issue.2, Part 1, pp.402-416, 2010.
DOI : 10.1097/AOG.0b013e3181e9322a

B. Sibai, A. Nazer, and A. Gonzalez-ruiz, Severe preeclampsia-eclampsia in young primigravid women: Subsequent pregnancy outcome and remote prognosis, American Journal of Obstetrics and Gynecology, vol.155, issue.5, pp.1011-1017, 1986.
DOI : 10.1016/0002-9378(86)90336-4

B. Sibai, B. Mercer, and C. Sarinoglu, Severe preeclampsia in the second trimester: Recurrence risk and long-term prognosis, American Journal of Obstetrics and Gynecology, vol.165, issue.4, pp.1408-1420, 1991.
DOI : 10.1016/S0002-9378(12)90773-5

J. Meekins, R. Pijnenborg, M. Hanssens, I. Mcfadyen, and A. Van-asshe, A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies, BJOG: An International Journal of Obstetrics and Gynaecology, vol.88, issue.8, pp.669-74, 1994.
DOI : 10.1111/j.1471-0528.1981.tb01268.x

D. Becroft, J. Thompson, and E. Mitchell, Placental Infarcts, Intervillous Fibrin Plaques, and Intervillous Thrombi: Incidences, Cooccurrences, and Epidemiological Associations, Pediatric and Developmental Pathology, vol.7, issue.1, pp.26-34, 2004.
DOI : 10.1007/s10024-003-4032-3

P. Marcorelles, Placenta de la pr????clampsie??: l??sions anatomiques et corr??lations anatomocliniques, Annales Fran??aises d'Anesth??sie et de R??animation, vol.29, issue.3, pp.25-29, 2010.
DOI : 10.1016/j.annfar.2010.02.013

M. Kupferminc, G. Fait, A. Many, J. Lessing, D. Yair et al., Low-Molecular-Weight Heparin for the Prevention of Obstetric Complications in Women with Thrombophilias, Hypertension in Pregnancy, vol.59, issue.1, pp.35-44, 2001.
DOI : 10.1016/0378-3782(86)90180-5

C. Touboul, Place des héparines de bas poids moléculaire dans la prévention des complications vasculaires gravidiques. Mises à jour en Obstétrique - CNGOF

B. Haddad, N. Winer, Y. Chitrit, V. Houfflin-debarge, C. Chauleur et al., LB1: Prevention of maternal and perinatal complications by??enoxaparin in women with previous severe preeclampsia (hepepe): an open-label, multicenter, prospective, randomized, controlled trial, American Journal of Obstetrics and Gynecology, vol.214, issue.1, p.452, 2016.
DOI : 10.1016/j.ajog.2015.11.034

S. Lisonkova, Y. Sabr, C. Mayer, C. Young, A. Skoll et al., Maternal Morbidity Associated With Early-Onset and Late-Onset Preeclampsia, Obstetrics & Gynecology, vol.124, issue.4, pp.771-81, 2014.
DOI : 10.1097/AOG.0000000000000472